Overview

Exelixis, Inc. is an oncology focused biotechnology company. The Company is engaged in the discovery, development, and commercialization of medicines to treat cancers. Its cabozantinib...

Open

$0.00

Prior close

$69.39

Today's high

$0.00

Today's low

$0.00

52 Week high

$72.10

52 Week low

$36.00

News

Zacks Investment Research • 21 hours ago • EXEL

Exelixis (EXEL) International Revenue in Focus: Trends and Expectations

Zacks Investment Research • 3 days ago • EXEL

EXEL Q3 Earnings Beat Estimates on Strong Cabometyx Sales

Seeking Alpha • 4 days ago • EXEL

Exelixis, Inc. (EXEL) Q3 2026 Earnings Call Transcript

MarketBeat • 4 days ago • EXEL

What Exelixis (EXEL) Said on Its Q3 Earnings Call

Zacks Investment Research • 4 days ago • EXEL

Exelixis (EXEL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates